Peretinoin, an acyclic retinoid, improves the hepatic gene signature of chronic hepatitis C following curative therapy of hepatocellular carcinoma

BACKGROUND: The acyclic retinoid, peretinoin, has been shown to be effective for suppressing hepatocellular carcinoma (HCC) recurrence after definitive treatment in a small-scale randomized clinical trial. However, little has been documented about the mechanism by which peretinoin exerts its inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Honda, Masao, Yamashita, Taro, Yamashita, Tatsuya, Arai, Kuniaki, Sakai, Yoshio, Sakai, Akito, Nakamura, Mikiko, Mizukoshi, Eishiro, Kaneko, Shuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660229/
https://www.ncbi.nlm.nih.gov/pubmed/23587162
http://dx.doi.org/10.1186/1471-2407-13-191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660229/
https://www.ncbi.nlm.nih.gov/pubmed/23587162
http://dx.doi.org/10.1186/1471-2407-13-191

Ejemplares similares